Osang Healthcare Co. Ltd.

As of March 31, 2026, Osang Healthcare Co. Ltd. carries a market capitalization of 120.46B, placing it among publicly traded companies globally. Its enterprise value stands at 130.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Osang Healthcare Co. Ltd. has 13.75M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 0.43.

As of March 31, 2026, Osang Healthcare Co. Ltd. trades at an EV/EBITDA multiple of 62.23 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.10 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 130.80B versus a market cap of 120.46B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Osang Healthcare Co. Ltd. maintains a current ratio of 2.59, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Osang Healthcare Co. Ltd. posted a negative return on equity (ROE) of -1.57, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.32, reflecting losses generated across the asset base. The company generates approximately 351.62M in revenue per employee across its workforce of 339.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.95 indicates how many times Osang Healthcare Co. Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Osang Healthcare Co. Ltd. recorded an income tax benefit of -626.05M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -5.07B and -4.43B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Osang Healthcare Co. Ltd.'s stock has declined approximately 58.12% over the past 52 weeks. The 50-day moving average sits at 6,564.60, while the 200-day moving average is 8,137.30.

Over the twelve months ended March 31, 2026, Osang Healthcare Co. Ltd. generated 119.38B in revenue and converted that into -4.43B in net income, yielding earnings per share of -322.57. EBITDA reached 2.10B, while operating income came in at -6.03B.

As of March 31, 2026, Osang Healthcare Co. Ltd. holds 38.50B in cash and equivalents against 48.57B in total debt, resulting in a net debt position of 29.49B. Total book value stands at 281.39B, with working capital of 60.52B providing operational flexibility.

Osang Healthcare Co. Ltd. produced 13.86B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -18.73B in capital expenditures, free cash flow totaled -4.87B - equivalent to -354.10 per share.

Over the twelve months ended March 31, 2026, Osang Healthcare Co. Ltd. posted a gross margin of 41.47, reflecting its pricing power and cost economics. The operating margin of -5.05 and net profit margin of -3.71 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Osang Healthcare Co. Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -4.04: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -9.53, meaning Osang Healthcare Co. Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Osang Healthcare Co. Ltd.'s most recent stock split took place on June 3, 2009 with a 2:3 split ratio.

As of March 31, 2026, Osang Healthcare Co. Ltd. has an Altman Z-Score of 2.64, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.